SOLIGENIX, INC. Shareholders' Equity
SOLIGENIX, INC. (SNGX) had Shareholders' Equity of $6.65 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $6.65M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.09M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.29M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $7.60M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $6.65M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $3.09M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $5.29M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $7.60M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $1.83M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $3.90M 10-Q · filed 2026-08-07 | $3.61M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $4.12M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $5.94M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $3.46M 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $768.37K 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $2.52M 10-K · filed 2026-03-31 | |
| 2023-09-30 | $4.22M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $5.80M 10-Q · filed 2024-11-08 | |
| 2023-03-31 | -$3.39M 10-Q · filed 2024-08-09 | |
| 2022-12-31 | -$2.47M 10-K · filed 2025-03-21 | |
| 2022-09-30 | $1.03M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $4.21M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $6.58M 10-Q · filed 2023-08-21 | |
| 2021-12-31 | $10.72M 10-K · filed 2024-03-15 | |
| 2021-09-30 | $15.05M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $15.60M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $17.32M 10-Q · filed 2022-08-12 | |
| 2020-12-31 | $3.74M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $7.41M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $6.03M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $3.51M 10-Q · filed 2021-08-13 | |
| 2019-12-31 | $1.46M 10-K · filed 2022-03-29 | |
| 2019-09-30 | $2.68M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $3.64M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $5.28M 10-Q · filed 2020-08-14 | |
| 2018-12-31 | $6.28M 10-K · filed 2021-03-30 | |
| 2018-09-30 | $9.27M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $2.62M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $4.07M 10-Q · filed 2019-08-13 | |
| 2017-12-31 | $6.32M 10-K · filed 2020-03-30 | |
| 2017-09-30 | $3.14M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $3.62M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $5.82M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $7.40M 10-K · filed 2019-03-26 | |
| 2016-09-30 | $2.17M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $33.89K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | -$1.05M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | -$18.31K 10-K · filed 2018-03-15 | |
| 2015-09-30 | -$466.22K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | -$3.52M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | -$1.83M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | -$153.89K 10-K · filed 2017-03-27 | |
| 2014-09-30 | -$4.28M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$4.66M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$4.11M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$1.77M 10-K · filed 2016-03-24 | |
| 2013-09-30 | -$3.60M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $2.45M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $2.58M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $3.55M 10-K · filed 2015-03-25 | |
| 2011-12-31 | $6.79M 10-K · filed 2014-03-26 | |
| 2010-12-31 | $7.36M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |